PL340604A1 - Application of macrolydes in treating tumours and maculopathy - Google Patents

Application of macrolydes in treating tumours and maculopathy

Info

Publication number
PL340604A1
PL340604A1 PL98340604A PL34060498A PL340604A1 PL 340604 A1 PL340604 A1 PL 340604A1 PL 98340604 A PL98340604 A PL 98340604A PL 34060498 A PL34060498 A PL 34060498A PL 340604 A1 PL340604 A1 PL 340604A1
Authority
PL
Poland
Prior art keywords
macrolydes
maculopathy
application
treating tumours
tumours
Prior art date
Application number
PL98340604A
Other languages
English (en)
Inventor
Yat Sun Or
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PL340604A1 publication Critical patent/PL340604A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL98340604A 1997-10-31 1998-10-30 Application of macrolydes in treating tumours and maculopathy PL340604A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (1)

Publication Number Publication Date
PL340604A1 true PL340604A1 (en) 2001-02-12

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340604A PL340604A1 (en) 1997-10-31 1998-10-30 Application of macrolydes in treating tumours and maculopathy

Country Status (17)

Country Link
EP (1) EP1027060A2 (ko)
JP (1) JP2001521891A (ko)
KR (1) KR20010031577A (ko)
CN (1) CN1278178A (ko)
AR (1) AR043071A1 (ko)
AU (1) AU1206799A (ko)
BG (1) BG104436A (ko)
BR (1) BR9813318A (ko)
CA (1) CA2307850A1 (ko)
HU (1) HUP0100012A3 (ko)
IL (1) IL135518A0 (ko)
NO (1) NO20002189L (ko)
PL (1) PL340604A1 (ko)
SK (1) SK6172000A3 (ko)
TR (1) TR200001147T2 (ko)
WO (1) WO1999022722A2 (ko)
ZA (1) ZA989885B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5037771B2 (ja) 2000-04-13 2012-10-03 バイオチカ テクノロジー リミテッド グリコシル化されたハイブリッド産物およびその産生方法と利用
EP1539157B1 (en) 2002-09-18 2013-08-21 Trustees Of The University Of Pennsylvania Rapamycin for use in inhibiting or preventing choroidal neovascularization
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
CA2520732C (en) 2003-03-28 2012-12-04 Sloan-Kettering Institute For Cancer Research Migrastatin analogs and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
US8957056B2 (en) 2004-05-25 2015-02-17 Sloan-Kettering Instiute For Cancer Research Migrastatin analogs in the treatment of cancer
US8188141B2 (en) 2004-09-23 2012-05-29 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
CA2615990A1 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
US8470985B2 (en) 2005-08-24 2013-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
US8278281B2 (en) 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
WO2007112052A2 (en) 2006-03-23 2007-10-04 Macusight, Inc. Formulations and methods for vascular permeability-related diseases or conditions
CN106317146B (zh) * 2015-06-18 2019-06-21 沈阳药科大学 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
KR20010031577A (ko) 2001-04-16
JP2001521891A (ja) 2001-11-13
HUP0100012A2 (hu) 2001-05-28
CN1278178A (zh) 2000-12-27
BG104436A (en) 2000-12-29
WO1999022722A3 (en) 1999-08-05
HUP0100012A3 (en) 2003-07-28
EP1027060A2 (en) 2000-08-16
TR200001147T2 (tr) 2000-08-21
NO20002189L (no) 2000-06-28
ZA989885B (en) 1999-05-05
WO1999022722A2 (en) 1999-05-14
BR9813318A (pt) 2000-08-22
AR043071A1 (es) 2005-07-20
CA2307850A1 (en) 1999-05-14
NO20002189D0 (no) 2000-04-27
IL135518A0 (en) 2001-05-20
SK6172000A3 (en) 2001-03-12
AU1206799A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
PL340604A1 (en) Application of macrolydes in treating tumours and maculopathy
GB2334444B (en) Hair treatment composition and method of manufacturing the composition
EP0964032A4 (en) NEW COMPOSITION AND TREATMENT
PL340014A1 (en) Agonists of prostagladins and their application in treating bone-related disoders
PL334678A1 (en) Quinolinic and quinazolinic compounds useful in therapy in particular in that of bph
ZA979096B (en) Viral and cancer treatment
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
HU9602965D0 (en) Cancer treatment and metastasis prevention
ZA985028B (en) Method of treating liver tumours and pharmaceutical compositions for use therein
IL129351A0 (en) Hiv and cancer treatment
PL320565A1 (en) Substances and their application
EP0758196A4 (en) COMPOSITIONS AND METHODS FOR TREATING TUMORS
HUP0004326A3 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
EP1119365A4 (en) COMPOSITIONS AND METHODS FOR USING TUMOR CELLS
PL324750A1 (en) Expressive construct p16 and posiibility of using it in treating carcinomas
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
HK1063004A1 (en) Oxalatoplatin and 5-fluorouracil for combination therapy of cancer
ZA981781B (en) The use of levobupivacaine in treating migraine
HUP9800146A3 (en) Thalidomide-derivatives and use of them
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
PL342055A1 (en) Application of hydropyridones containing powders in treating crural ulcerations and bedsores
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
GB9606293D0 (en) Treatment of cancers and other tumours